Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Bexxar as first-line therapy for non-Hodgkin's lymphoma

May 26, 1997

Preliminary phase II and phase I/II results for Allovectin-7

May 22, 1997

Preliminary results indicate potential for AML treatment

May 21, 1997

Techniclone reports promising results from brain cancer treatment study

May 21, 1997

Somatix reports promising results from melanoma vaccine trials

May 21, 1997

Ribi theraccine available for licensing outside Canada

May 19, 1997

NIH announces prospective grant of exclusive license for IL-13 receptor-specific chimeric antibodies

May 16, 1997

Phase I/II results for Glaxo's tucaresol in metastatic melanoma

May 15, 1997

Ilex and LeukoSite form joint venture for development of Campath-1H

May 14, 1997

Ono-4007 restores immune responses in tumor-bearing animals

May 12, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 10, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026